Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 2, Pages 193
Publisher
MDPI AG
Online
2019-02-23
DOI
10.3390/cells8020193
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
- (2018) Stéphanie Da Silva et al. INFLAMMATORY BOWEL DISEASES
- P851 Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitis
- (2018) L Koeninger et al. Journal of Crohns & Colitis
- A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage
- (2018) Vu L. Ngo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn’s disease via effects on epithelial lipid rafts
- (2018) Olena Yakymenko et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- C1orf106is a colitis risk gene that regulates stability of epithelial adherens junctions
- (2018) Vishnu Mohanan et al. SCIENCE
- Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
- (2018) Maria Lia Scribano WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease
- (2018) Shu-Ling Wang et al. Frontiers in Immunology
- Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages
- (2018) Rui Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death
- (2018) Ricard Garcia-Carbonell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis
- (2018) Christina L. Hayes et al. Scientific Reports
- The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
- (2018) Tao Zuo et al. Frontiers in Microbiology
- Mast cells at the crossroads of microbiota and IBD
- (2018) Marco De Zuani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD
- (2018) Kenechukwu O Chudy-Onwugaje et al. INFLAMMATORY BOWEL DISEASES
- Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes
- (2018) Abbi R. Saniabadi et al. JOURNAL OF CLINICAL APHERESIS
- Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis
- (2018) Maite Casado-Bedmar et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation
- (2018) Knud Bach Knudsen et al. Nutrients
- MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice
- (2017) Federica Ungaro et al. GASTROENTEROLOGY
- Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
- (2017) Stephan J. Ott et al. GASTROENTEROLOGY
- Adherent-invasiveEscherichia coliin inflammatory bowel disease
- (2017) Carolina Palmela et al. GUT
- Update on the Therapeutic Efficacy of Tregs in IBD
- (2017) Massimo C. Fantini et al. INFLAMMATORY BOWEL DISEASES
- A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn’s Disease and Control Subjects
- (2017) John-Peter Ganda Mall et al. INFLAMMATORY BOWEL DISEASES
- The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
- (2017) Grainne Holleran et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease
- (2017) Guang Xi Zhou et al. Journal of Digestive Diseases
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- The Interplay between Defensins and Microbiota in Crohn’s Disease
- (2017) Lorena Coretti et al. MEDIATORS OF INFLAMMATION
- Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
- (2017) Nathaniel R West et al. NATURE MEDICINE
- Gut microbiota and IBD: causation or correlation?
- (2017) Josephine Ni et al. Nature Reviews Gastroenterology & Hepatology
- Role of autophagy in the pathogenesis of inflammatory bowel disease
- (2017) Tomoya Iida et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nod2: The intestinal gate keeper
- (2017) Ziad Al Nabhani et al. PLoS Pathogens
- Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study
- (2017) Beatriz Lobo et al. United European Gastroenterology Journal
- Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
- (2017) Jesmond Dalli et al. Frontiers in Immunology
- Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases
- (2017) Federica Ungaro et al. Frontiers in Immunology
- Probiotics and the Gut Immune System: Indirect Regulation
- (2017) Giorgio La Fata et al. Probiotics and Antimicrobial Proteins
- Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
- (2017) Paul W. O’Toole et al. Nature Microbiology
- Dynamics of the human gut microbiome in inflammatory bowel disease
- (2017) Jonas Halfvarson et al. Nature Microbiology
- Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages
- (2016) Ilana Gabanyi et al. CELL
- Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway
- (2016) Hong-Qian Chu et al. DIGESTIVE AND LIVER DISEASE
- Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study
- (2016) Christian L. Hvas et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Mast cell stabilisers
- (2016) Tao Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Protease inhibition as new therapeutic strategy for GI diseases
- (2016) Nathalie Vergnolle GUT
- Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation
- (2016) Masakazu Shinohara et al. Journal of Atherosclerosis and Thrombosis
- CX3CR1+Cell–MediatedSalmonellaExclusion Protects the Intestinal Mucosa during the Initial Stage of Infection
- (2016) Angela L. Man et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of inflammation-driven bacterial dysbiosis in the gut
- (2016) M Y Zeng et al. Mucosal Immunology
- Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
- (2016) R K Boyapati et al. Mucosal Immunology
- Tocilizumab and the risk of intestinal perforation
- (2016) Lydia Shipman Nature Reviews Rheumatology
- Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases
- (2016) Caroline Meyer Olesen et al. PHARMACOLOGY & THERAPEUTICS
- Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications
- (2016) Daniel Muthas et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mucosa-attached bacterial community in Crohn's disease coheres with the clinical disease activity index
- (2016) Holger Schäffler et al. Environmental Microbiology Reports
- An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity
- (2016) Artemis Simopoulos Nutrients
- Neutrophils: Their Role in Innate and Adaptive Immunity
- (2016) Carlos Rosales et al. Journal of Immunology Research
- Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel disease
- (2016) Sara Al-Ghadban et al. Scientific Reports
- Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease
- (2015) Shuhei Hosomi et al. CURRENT OPINION IN GASTROENTEROLOGY
- Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage
- (2015) Gao Tan et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
- (2015) Andrea Michielan et al. MEDIATORS OF INFLAMMATION
- Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
- (2015) Benoit Chassaing et al. NATURE
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Epidemiology and risk factors for IBD
- (2015) Ashwin N. Ananthakrishnan Nature Reviews Gastroenterology & Hepatology
- Omega-3 fatty acids and inflammation: A perspective on the challenges of evaluating efficacy in clinical research
- (2015) Ann C. Skulas-Ray PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The resolution of inflammation: Principles and challenges
- (2015) Sarah E. Headland et al. SEMINARS IN IMMUNOLOGY
- The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
- (2015) Charles N. Serhan et al. SEMINARS IN IMMUNOLOGY
- Role of interleukin-22 in inflammatory bowel disease
- (2015) Lin-Jing Li WORLD JOURNAL OF GASTROENTEROLOGY
- First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
- (2014) Max Karner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages
- (2014) Yasutaka Okabe et al. CELL
- Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
- (2014) Filipe De Vadder et al. CELL
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- IBD Candidate Genes and Intestinal Barrier Regulation
- (2014) Declan F. McCole INFLAMMATORY BOWEL DISEASES
- Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
- (2014) Ruben J. Colman et al. Journal of Crohns & Colitis
- Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
- (2014) Calum C Bain et al. NATURE IMMUNOLOGY
- Immunopathology of inflammatory bowel disease
- (2014) Kori L Wallace WORLD JOURNAL OF GASTROENTEROLOGY
- Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
- (2013) Christopher G. Mayne et al. INFLAMMATORY BOWEL DISEASES
- Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
- (2013) W. Wang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity
- (2013) Daniel S. Pearl et al. Journal of Crohns & Colitis
- Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats
- (2013) Å. V. Keita et al. NEUROGASTROENTEROLOGY AND MOTILITY
- P03-024 – Early onset IBD treated by tocilizumab
- (2013) R Helbling et al. Pediatric Rheumatology
- Altered Colonic Mucosal Polyunsaturated Fatty Acid (PUFA) Derived Lipid Mediators in Ulcerative Colitis: New Insight into Relationship with Disease Activity and Pathophysiology
- (2013) Mojgan Masoodi et al. PLoS One
- Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis
- (2013) Anders H Carlsson et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
- (2013) Gary R. Lichtenstein Therapeutic Advances in Gastroenterology
- Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
- (2012) Lawrence J Brandt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Abnormal Activation of Autophagy-Induced Crinophagy in Paneth Cells From Patients With Crohn's Disease
- (2012) Élodie Thachil et al. GASTROENTEROLOGY
- Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
- (2012) Pierre Desreumaux et al. GASTROENTEROLOGY
- Ly6Chi Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells
- (2012) Ehud Zigmond et al. IMMUNITY
- Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers
- (2012) Megan E. Himmel et al. IMMUNOLOGY
- Healing of intestinal inflammation by IL-22
- (2012) Atsushi Mizoguchi INFLAMMATORY BOWEL DISEASES
- Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins
- (2012) Ean-jeong Seo et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Inflammation switches the differentiation program of Ly6Chimonocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon
- (2012) Aymeric Rivollier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-TNF, Infliximab, and Adalimumab Can Be Effective in Eosinophilic Bowel Disease
- (2012) Dan Turner et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications
- (2012) Jane M.M. Natividad et al. PHARMACOLOGICAL RESEARCH
- Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel Disease
- (2011) Bernadette Begue et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Life and Death of Epithelia During Inflammation: Lessons Learned from the Gut
- (2011) Stefan Koch et al. Annual Review of Pathology-Mechanisms of Disease
- Intestinal mast cells in gut inflammation and motility disturbances
- (2011) Benedicte Y. De Winter et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
- (2011) Zhenhua Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inflammation and wound healing: the role of the macrophage
- (2011) Timothy J. Koh et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Eosinophils Express Muscarinic Receptors and Corticotropin-Releasing Factor to Disrupt the Mucosal Barrier in Ulcerative Colitis
- (2011) Conny Wallon et al. GASTROENTEROLOGY
- Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
- (2011) Patricia Lepage et al. GASTROENTEROLOGY
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
- (2011) M. Joossens et al. GUT
- Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog
- (2011) Maya Saleh et al. IMMUNITY
- Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria
- (2011) Usriansyah Hadis et al. IMMUNITY
- Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host
- (2011) Jaclyn Strauss et al. INFLAMMATORY BOWEL DISEASES
- Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
- (2011) Anne Christine W. Vos et al. INFLAMMATORY BOWEL DISEASES
- Recent advances in IL-22 biology
- (2011) L. A. Zenewicz et al. INTERNATIONAL IMMUNOLOGY
- Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease
- (2011) Marc Girardin et al. Journal of Crohns & Colitis
- Autophagy in immunity and inflammation
- (2011) Beth Levine et al. NATURE
- Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
- (2010) Charles N. Serhan AMERICAN JOURNAL OF PATHOLOGY
- Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: A report based on 120 patients with active ulcerative colitis
- (2010) Tomotaka Tanaka et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
- (2010) Ben P. Willing et al. GASTROENTEROLOGY
- Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
- (2010) Anne Christine W. Vos et al. GASTROENTEROLOGY
- The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
- (2010) T. K. Klooker et al. GUT
- Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
- (2010) B. Jharap et al. INFLAMMATORY BOWEL DISEASES
- Is metabolic stress a common denominator in inflammatory bowel disease?
- (2010) Ida Schoultz et al. INFLAMMATORY BOWEL DISEASES
- Monocyte Chemoattractant Protein-1 Contributes to Gut Homeostasis and Intestinal Inflammation by Composition of IL-10–Producing Regulatory Macrophage Subset
- (2010) Yasuhiro Takada et al. JOURNAL OF IMMUNOLOGY
- Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells
- (2010) å. v. Keita et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Epithelial crosstalk at the microbiota-mucosal interface
- (2010) J. M. Wells et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease
- (2010) Patrick Danoy et al. PLoS Genetics
- Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
- (2009) R. CORINALDESI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine
- (2009) P-Y Zheng et al. GUT
- Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease
- (2009) A. M. Muise et al. GUT
- Comparative anatomy and phylogenetic distribution of the mammalian cecal appendix
- (2009) H. F. SMITH et al. JOURNAL OF EVOLUTIONARY BIOLOGY
- Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease
- (2009) A. Andoh et al. JOURNAL OF IMMUNOLOGY
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans
- (2009) M Möndel et al. Mucosal Immunology
- Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
- (2009) Mark S Silverberg et al. NATURE GENETICS
- Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region
- (2009) Jeffrey C Barrett et al. NATURE GENETICS
- XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
- (2008) Arthur Kaser et al. CELL
- In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients
- (2008) T. Tanaka et al. DIGESTIVE AND LIVER DISEASE
- High-frequency Haplotypes in the X Chromosome Locus TLR8 Are Associated With Both CD and UC in Females
- (2008) Masayuki Saruta et al. INFLAMMATORY BOWEL DISEASES
- IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
- (2008) Ken Sugimoto et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
- (2008) Jeffrey C Barrett et al. NATURE GENETICS
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started